{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:04:00Z","timestamp":1790503440344,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:00:00Z","timestamp":1565740800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:00:00Z","timestamp":1565740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12890-019-0907-6","type":"journal-article","created":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T16:03:10Z","timestamp":1565798590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6021-8237","authenticated-orcid":false,"given":"Conor D.","family":"Tweed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Crook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas H.","family":"Diacon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D.","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl M.","family":"Mendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K.","family":"Meredith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lerato","family":"Mohapi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Nunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick P. J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasha P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin","family":"Spigelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,14]]},"reference":[{"key":"907_CR1","unstructured":"WHO. Global Tuberculosis Report 2017. Geneva; 2017."},{"key":"907_CR2","first-page":"1","volume":"3","author":"MT Montales","year":"2015","unstructured":"Montales MT, Chaudhury A, Beebe A, Patil S, Patil N. HIV-associated TB Syndemic: a growing clinical challenge worldwide. Front Public Heal. 2015;3:1\u20137.","journal-title":"Front Public Heal"},{"key":"907_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/nrmicro.2017.128","volume":"16","author":"LCK Bell","year":"2017","unstructured":"Bell LCK, Noursadeghi M. Pathogenesis of HIV-1 and mycobacterium tuberculosis co-infection. Nat Rev Microbiol Nature Publishing Group. 2017;16:80\u201390.","journal-title":"Nat Rev Microbiol Nature Publishing Group"},{"key":"907_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1128\/CMR.00042-10","volume":"24","author":"C Kwan","year":"2011","unstructured":"Kwan C, Ernst JD. HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev. 2011;24:351\u201376.","journal-title":"Clin Microbiol Rev"},{"key":"907_CR5","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.5588\/ijtld.13.0032","volume":"17","author":"RK Gupta","year":"2013","unstructured":"Gupta RK, Lawn SD, Bekker L-G, Caldwell J, Kaplan R, Wood R, et al. Impact of human immunodeficiency virus and CD4 count on tuberculosis diagnosis: analysis of city-wide data from Cape Town, South Africa. Int J Tuberc Lung Dis. 2013;17:1014\u201322.","journal-title":"Int J Tuberc Lung Dis"},{"key":"907_CR6","first-page":"393","volume":"131","author":"AE Pitchenik","year":"1985","unstructured":"Pitchenik AE, Rubinson HA. The radiographic appearance of tuberculosis in patients with the acquired immune deficiency syndrome (AIDS) and pre-AIDS. Am Rev Respir Dis. 1985;131:393\u20136.","journal-title":"Am Rev Respir Dis"},{"key":"907_CR7","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1086\/514546","volume":"25","author":"DC Perlman","year":"1997","unstructured":"Perlman DC, El-sadr WM, Nelson ET, Matts JP, Telzak EE, Salomon N, et al. Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. Clin Infect Dis. 1997;25:242\u20136.","journal-title":"Clin Infect Dis"},{"key":"907_CR8","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/S0140-6736(07)60284-0","volume":"369","author":"H Getahun","year":"2007","unstructured":"Getahun H, Harrington M, O\u2019Brien R, Nunn P. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet. 2007;369:2042\u20139.","journal-title":"Lancet."},{"key":"907_CR9","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1001\/jama.1996.03540150025026","volume":"276","author":"A Pablos M\u00e9ndez","year":"1996","unstructured":"Pablos M\u00e9ndez A, Sterling TR, Frieden TR. The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. J Am Med Assoc. 1996;276:1223\u20138.","journal-title":"J Am Med Assoc"},{"key":"907_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s15010-002-2062-9","volume":"30","author":"F Palmieri","year":"2002","unstructured":"Palmieri F, Girardi E, Pellicelli AM, Rianda A, Bordi E, Busi Rizzi E, et al. Pulmonary tuberculosis in HIV-infected patients presenting with normal chest radiograph and negative sputum smear. Infection. 2002;30:68\u201374.","journal-title":"Infection."},{"key":"907_CR11","first-page":"968","volume":"4","author":"H Banda","year":"2000","unstructured":"Banda H, Kang\u2019ombe C, Harries AD, Nyangulu DS, Whitty CJM, Wirima JJ, et al. Mortality rates and recurrent rates of tuberculosis in patients with smear-negative pulmonary tuberculosis and tuberculous pleural effusion who have completed treatment. Int J Tuberc Lung Dis. 2000;4:968\u201374.","journal-title":"Int J Tuberc Lung Dis"},{"key":"907_CR12","first-page":"847","volume":"5","author":"NJ Hargreaves","year":"2001","unstructured":"Hargreaves NJ, Kadzakumanja O, Whitty CJM, Salaniponi FML, Harries AD, Squire SB. \u201cSmear-negative\u201d pulmonary tuberculosis in a DOTS programme: poor outcomes in an area of high HIV seroprevalence. Int J Tuberc Lung Dis. 2001;5:847\u201354.","journal-title":"Int J Tuberc Lung Dis"},{"key":"907_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1186\/s13104-015-1452-x","volume":"8","author":"G Tesfahuneygn","year":"2015","unstructured":"Tesfahuneygn G, Medhin G, Legesse M. Adherence to anti-tuberculosis treatment and treatment outcomes among tuberculosis patients in Alamata District, Northeast Ethiopia. BMC Res Notes BioMed Central. 2015;8:503.","journal-title":"BMC Res Notes BioMed Central"},{"key":"907_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0019566","volume":"6","author":"N Lorent","year":"2011","unstructured":"Lorent N, Sebatunzi O, Mukeshimana G, van den Ende J, Clerinx J. Incidence and risk factors of serious adverse events during antituberculous treatment in Rwanda: a prospective cohort study. Pai M, editor. PLoS One. 2011;6:1\u20138.","journal-title":"PLoS One"},{"key":"907_CR15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/01.qai.0000152400.36723.85","volume":"39","author":"MS Dworkin","year":"2005","unstructured":"Dworkin MS, Adams MR, Cohn DL, Davidson AJ, Buskin S, Horwitch C, et al. Factors that complicate the treatment of tuberculosis in HIV-infected patients. J Acquir Immune Defic Syndr. 2005;39:464\u201370.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"907_CR16","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1164\/rccm.200206-626OC","volume":"167","author":"D Yee","year":"2003","unstructured":"Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D. Incidence of serious side effects from first-line Antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med. 2003;167:1472\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"907_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-9-1","volume":"9","author":"J Zhou","year":"2009","unstructured":"Zhou J, Elliott J, Li PCK, Lim PL, Kiertiburanakul S, Kumarasamy N, et al. Risk and prognostic significance of tuberculosis in patients from the TREAT Asia HIV observational database. BMC Infect Dis. 2009;9:1\u20139.","journal-title":"BMC Infect Dis"},{"key":"907_CR18","doi-asserted-by":"publisher","first-page":"S201","DOI":"10.1086\/651492","volume":"50","author":"H Getahun","year":"2010","unstructured":"Getahun H, Gunneberg C, Granich R, Nunn P. HIV infection\u2013associated tuberculosis: the epidemiology and the response. Clin Infect Dis. 2010;50:S201\u20137.","journal-title":"Clin Infect Dis"},{"key":"907_CR19","first-page":"1","volume":"8","author":"I Ismail","year":"2013","unstructured":"Ismail I, Bulgiba A. Predictors of death during tuberculosis treatment in TB\/HIV co-infected patients in Malaysia. PLoS One. 2013;8:1\u20137.","journal-title":"PLoS One"},{"key":"907_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/01.qai.0000230521.86964.86","volume":"43","author":"W Manosuthi","year":"2006","unstructured":"Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S. Survival rate and risk factors of mortality among HIV\/tuberculosis-Coinfected patients with and without antiretroviral therapy. J Acquir Immune Defic Syndr. 2006;43:42\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"907_CR21","unstructured":"World Health Organisation. The use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a Public Health Approach. Geneva; 2016."},{"key":"907_CR22","volume-title":"Global Data Report","author":"UNAIDS","year":"2017","unstructured":"UNAIDS. Global Data Report. 2017."},{"key":"907_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/pan\/mpr013","volume":"20","author":"SM Iacus","year":"2012","unstructured":"Iacus SM, King G, Porro G. Causal inference without balance checking: coarsened exact matching. Polit Anal. 2012;20:1\u201324.","journal-title":"Polit Anal"},{"key":"907_CR24","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1177\/1536867X0900900402","volume":"9","author":"HJ Newton","year":"2009","unstructured":"Newton HJ, Baum CF, Beck N, Cameron a C, Epstein D, Hardin J, et al. Cem: coarsened exact matching in Stata. Stata J. 2009;9:524\u201346.","journal-title":"Stata J"},{"key":"907_CR25","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1080\/01621459.1962.10480664","volume":"57","author":"A Zellner","year":"1962","unstructured":"Zellner A. An efficient method of estimating seemingly unrelated regression equations and tests for aggregation bias. J Am Stat Assoc. 1962;57:348\u201368.","journal-title":"J Am Stat Assoc"},{"key":"907_CR26","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S0140-6736(14)60164-1","volume":"384","author":"G Maartens","year":"2014","unstructured":"Maartens G, Celum C, Lewin SR. HIV infection: epidemiology, pathogenesis, treatment, and prevention. Lancet. 2014;384:258\u201371.","journal-title":"Lancet"},{"key":"907_CR27","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1086\/652147","volume":"50","author":"S Swaminathan","year":"2010","unstructured":"Swaminathan S, Padmapriyadarsini C, Narendran G. HIV-associated tuberculosis: clinical update. Clin Infect Dis. 2010;50:1377\u201386.","journal-title":"Clin Infect Dis"},{"key":"907_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12981-015-0076-5","volume":"12","author":"DJ Pepper","year":"2015","unstructured":"Pepper DJ, Schomaker M, Wilkinson RJ, Azevedo V, Maartens G. Independent predictors of tuberculosis mortality in a high HIV prevalence setting: a retrospective cohort study. AIDS Res Ther BioMed Central. 2015;12:35.","journal-title":"AIDS Res Ther BioMed Central"},{"key":"907_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/1741-7015-11-253","volume":"11","author":"SD Lawn","year":"2013","unstructured":"Lawn SD, Meintjes G, Mcilleron H, Harries AD, Wood R. Management of HIV-associated tuberculosis in resource-limited settings : a state-of-the-art review. BMC Med. 2013;11:253.","journal-title":"BMC Med"},{"key":"907_CR30","unstructured":"WHO. WHO policy on collaborative TB\/HIV activities guidelines for national programmes and other stakeholders. Geneva; 2012."},{"key":"907_CR31","unstructured":"WHO. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource- constrained settings department. Geneva; 2011."},{"key":"907_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000391","volume":"8","author":"H Getahun","year":"2011","unstructured":"Getahun H, Kittikraisak W, Heilig CM, Corbett EL, Ayles H, Cain KP, et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med. 2011;8:e1000391.","journal-title":"PLoS Med"},{"key":"907_CR33","doi-asserted-by":"crossref","unstructured":"Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N. Xpert\u00ae MTB\/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2014:CD009593.","DOI":"10.1002\/14651858.CD009593.pub3"},{"key":"907_CR34","unstructured":"WHO. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB\/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children. Geneva; 2013."},{"key":"907_CR35","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1183\/13993003.00543-2016","volume":"48","author":"H Albert","year":"2016","unstructured":"Albert H, Nathavitharana RR, Isaacs C, Pai M, Denkinger CM, Boehme CC. Development, roll-out and impact of Xpert MTB\/RIF for tuberculosis: what lessons have we learnt and how can we do better? Eur Respir J. 2016;48:516\u201325.","journal-title":"Eur Respir J"},{"key":"907_CR36","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/cid\/ciw566","volume":"63","author":"P Nahid","year":"2016","unstructured":"Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, et al. Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis. 2016;63:853\u201367.","journal-title":"Clin Infect Dis"},{"key":"907_CR37","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12879-018-3230-6","volume":"18","author":"CD Tweed","year":"2018","unstructured":"Tweed CD, Crook AM, Amukoye EI, Dawson R, Diacon AH, Hanekom M, et al. Toxicity associated with tuberculosis chemotherapy in the REMoxTB study. BMC Infect Dis. 2018;18:317.","journal-title":"BMC Infect Dis"},{"key":"907_CR38","unstructured":"World Health Organisation. WHO policy on collaborative TB\/HIV activities guidelines for national programmes and other stakeholders. Geneva; 2012."},{"key":"907_CR39","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1056\/NEJMoa1013911","volume":"365","author":"F-X Blanc","year":"2011","unstructured":"Blanc F-X, Sok T, Laureillard D, Borand L, Rekacewicz C, Nerrienet E, et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med. 2011;365:1471\u201381.","journal-title":"N Engl J Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-019-0907-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12890-019-0907-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-019-0907-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T23:12:08Z","timestamp":1597273928000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-019-0907-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,14]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["907"],"URL":"https:\/\/doi.org\/10.1186\/s12890-019-0907-6","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,14]]},"assertion":[{"value":"16 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients provided written consent to any data and samples collected as part of the trial being used in further studies to improve the diagnosis and treatment of tuberculosis, as stated on the informed consent form for the study. Ethics approval was granted for REMoxTB by the ethics board at University College London, and at each of the study sites:Kenya\nSouth Africa\nTanzania\nZambia\nChina\nIndia\nMexico\nThailand\nMalaysia","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None declared.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"152"}}